Voya Investment Management LLC Syros Pharmaceuticals, Inc. Transaction History

Voya Investment Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.69 - $1.21 $27,422 - $48,089	-39,743 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.02 - $3.8 $14,644 - $54,556	14,357 Added 56.55%	39,743 $47,000
Q4 2021 Feb 14, 2022	BUY	$3.26 - $4.66 $8,837 - $12,633	2,711 Added 11.96%	25,386 $83,000
Q2 2021 Aug 16, 2021	BUY	$5.01 - $7.48 $12,735 - $19,014	2,542 Added 12.63%	22,675 $124,000
Q1 2021 May 17, 2021	BUY	$7.19 - $14.95 $7,067 - $14,695	983 Added 5.13%	20,133 $151,000
Q4 2020 Feb 16, 2021	BUY	$6.66 - $14.66 $29,197 - $64,269	4,384 Added 29.69%	19,150 $208,000
Q2 2020 Aug 14, 2020	SELL	$5.21 - $11.03 $19,943 - $42,222	-3,828 Reduced 20.59%	14,766 $157,000
Q4 2019 Feb 14, 2020	BUY	$4.52 - $10.1 $22,563 - $50,419	4,992 Added 36.7%	18,594 $128,000
Q2 2019 Aug 14, 2019	BUY	$5.5 - $9.75 $17,798 - $31,551	3,236 Added 31.22%	13,602 $126,000
Q1 2019 May 15, 2019	BUY	$5.51 - $9.59 $57,116 - $99,409	10,366 New	10,366 $95,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.